OssDsign gets FDA clearance for facial reconstruction January 20, 2017 -- Swedish cranial and facial reconstruction implant firm OssDsign said it has received U.S. Food and Drug Administration (FDA) clearance for its flagship OssDsign Cranial product for reconstructing defects during cranioplasty via 3D-printed implants.
Scientists use DTI-MRI to map Tasmanian tiger brain January 19, 2017 -- Scientists have used MRI and diffusion-tensor imaging (DTI) to reconstruct the brain architecture and neural networks of the thylacine, or Tasmanian tiger, an extinct carnivorous marsupial native to Tasmania, according to research published online January 18 in PLOS One.
EMA continues investigation of gadolinium contrast agents January 18, 2017 -- Ten months after it began its review of gadolinium contrast agents, the European Medicines Agency (EMA) has announced it is still continuing to assess the risk of gadolinium being deposited in brain tissue following MRI scans.
ESR expands collaboration with CIRSE January 18, 2017 -- The European Society of Radiology (ESR) and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) have extended their cooperation in order to fortify the position of diagnostic and interventional radiology and to attract more clinically oriented medical students to radiology.
RSNA attendance bounces back 4% in 2016 January 18, 2017 -- Attendance at RSNA 2016 grew by 4% over the 2015 edition of the conference, but it still fell shy of the mark set by the meeting in 2014.
EOS revenues climb in Q4, 2016 January 18, 2017 -- An increase in system sales helped orthopedic digital imaging developer EOS Imaging produce a 46% increase in revenues in its fourth quarter.
Siemens expands online learning platform January 18, 2017 -- Siemens Healthineers is expanding its PEPconnect online learning platform to include approximately 1,000 new learning modules for medical imaging customers.
Advanced MR Analytics secures large investment January 18, 2017 -- Advanced MR Analytics (AMRA) has received an investment of approximately 8.5 million euros ($9 million U.S.) from U.S.-based Pfizer Venture Investments, Nordic VC Novo Seeds, and Industrifonden, another AMRA investor.